Dapre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dapre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dapre Today - Breaking & Trending Today

FY2028 EPS Estimates for Aprea Therapeutics, Inc. (NASDAQ:APRE) Cut by Analyst

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Analysts at Wedbush reduced their FY2028 earnings per share estimates for Aprea Therapeutics in a research report issued to clients and investors on Tuesday, May 14th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of $0.77 per share for the year, down from […] ....

Berndr Seizinger , Aprea Therapeutics Company Profile , Aprea Therapeutics Inc , Aprea Therapeutics , Free Report , Aprea Therapeutic , Get Free Report , Director Bernd , Aprea Therapeutics Daily , Nasdaq Apre , Earnings Estimates ,

Aprea Therapeutics (NASDAQ:APRE) Price Target Increased to $11.00 by Analysts at Wedbush

Aprea Therapeutics (NASDAQ:APRE – Free Report) had its price target boosted by Wedbush from $9.00 to $11.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has an outperform rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $20.00 price target on shares of […] ....

Berndr Seizinger , Aprea Therapeutics Inc , Royal Bank , Geode Capital Management , Millennium Management , Vanguard Group Inc , Renaissance Technologies , Securities Exchange Commission , Aprea Therapeutics , Free Report , Therapeutics Stock Down , Director Bernd , Exchange Commission , Capital Management , Get Free Report , Aprea Therapeutics Daily , Nasdaq Apre , Boost Price Target ,